N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
about
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraRoutine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraRaised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndromeB-type natriuretic peptide-guided treatment for heart failure.Quick identification of acute chest pain patients study (QICS).Biomarkers in acute myocardial infarction.Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study.Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary studyAdmission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure.The prognostic value of N-terminal proB-type natriuretic peptide.Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine"Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes.Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary SyndromeMultimarker strategy in acute coronary syndrome--pro-multimarker.Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice?Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins.Diagnosis and management of patients with suspected acute myocardial infarction.NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials.Endothelial immunomediated reactivity in acute cardiac ischaemia: Role of endothelin 1, interleukin 8 and NT-proBNP in patients affected by unstable angina pectoris.Natriuretic peptides for risk stratification of patients with acute coronary syndromes.Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.Biomarkers for the prediction of major adverse cardiovascular events in patients with acute coronary syndrome.Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure.NT-ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non-ST-elevation acute coronary syndrome.N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.Risk prediction in acute coronary syndrome from serial in-hospital measurements of N-terminal pro-B-type natriuretic peptide.Cardiovascular Biomarkers in ACS: State of the Art 2012
P2860
Q24236794-36F1DC8F-0E14-40B9-BAAB-F60396BF02ECQ26471900-7BFC5D03-251E-4ADF-AF08-44D5AF44B7FEQ28219323-B6CF6905-CC2F-4859-8AB6-C592D6E7B9DCQ30238936-B560A512-93FC-4B04-A0E1-DEF6FC552E35Q33467558-405F99D2-FFDE-4799-919C-ADDE04A5499AQ33596823-F167BD3D-F7E0-4E72-8240-FBDF77B5BB3EQ34181625-D5BA96A7-02CA-4BCC-B7A5-2D6EEC44E158Q35025805-ACACC68F-C5C1-4088-925B-EFDED7C8EE7DQ35770822-C7378CD9-CBAC-4F2D-B4A5-EDEC24D6B3FBQ36124913-A84B83DD-38B4-4240-8DFB-B479941714F8Q36304293-2723372B-0606-42D9-B8EE-ABE61B840AD8Q36477929-19FD1467-C6EB-4AEE-96E6-325B4C0CDF0FQ36601665-B867BEE7-8CB5-461E-B01D-EF263B9ACC32Q36738245-0D8A4551-BE6D-417B-99C5-04E47B133CBEQ36799327-3D9CD0B0-7946-44BB-AFAE-82204877D24AQ37182338-F91C55FF-424B-4FCE-8F90-2608D7F15285Q37277937-8ADD76E9-522C-46F9-BA66-E1032DFA408EQ37835560-DD659616-31DA-46CB-A048-D190F7A97F05Q38144914-B12F47EA-E78F-4594-807A-5B066CFA165BQ39185614-500C2151-85B6-4397-A1C2-179299B1A419Q40395526-73C62188-5FDA-4EEA-882F-DDA9EB714767Q44273459-04361A61-0C3E-46E3-9C6C-4572EC475DEBQ44831010-7F35A1D9-0669-48A2-A648-46434C4BB6A6Q48030135-E082D0D2-E2AF-4120-8BAD-A0B765246530Q48107446-371A5C52-7F49-4430-A37E-91CA5690686EQ48115682-4F8CEE67-EF8E-4A72-8A39-9A361BE0CB7DQ48409814-CFDFA79C-7379-4848-8FF9-81BCED74058EQ48525307-FE81BD13-C9DE-4378-ACC0-04BB2B75384AQ48787347-F8E88798-6610-4516-975D-04008241DC3DQ49111539-C7811494-568B-489F-B1F4-F1D9665899D6Q58919589-42E7A1E4-0440-4327-A60F-2AF131D4D93F
P2860
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
N-terminal pro-brain natriuret ...... table coronary artery disease.
@en
type
label
N-terminal pro-brain natriuret ...... table coronary artery disease.
@en
prefLabel
N-terminal pro-brain natriuret ...... table coronary artery disease.
@en
P2093
P1476
N-terminal pro-brain natriuret ...... table coronary artery disease.
@en
P2093
Bertil Andren
Bertil Lindahl
Bo Lagerqvist
Gunnar Frostfeldt
Mats Stridsberg
Tomas Jernberg
P304
P356
10.1016/J.JACC.2003.07.015
P407
P577
2003-12-01T00:00:00Z